Decline in breast cancer: Not just because of hormone therapy

Dec 08, 2009

Between 2002 and 2003, American women experienced a 7 percent decline in breast cancer incidence, which scientists attribute to the publicity surrounding results of the Women's Health Initiative (WHI).

However, researchers led by Brian Sprague, Ph.D. have conducted a reevaluation of the post-WHI landscape that suggests otherwise.

"We found that the change in hormone therapy use only accounted for a decline of about 3 percent, so there's another 4 percent that is being caused by something we do not yet know," said Sprague, a postdoctoral fellow at the University of Wisconsin.

Results of this study were presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9 in Houston.

In 1991, the National Institutes of Health established the WHI to address the most common causes of death, disability and deterred quality of life among 15,730 postmenopausal — cancer, cardiovascular disease and osteoporosis.

Results of the WHI demonstrated in 2002 that hormone therapy is linked with an increased risk of . Other studies have confirmed this relationship, and many women have stopped taking hormone therapy due to concerns about the potential risk of cancer. At the same time, the incidence of breast cancer has declined, which researchers attribute to the decrease in hormone therapy use.

After conducting a thorough literature review of the decline in hormone use and the decline in breast cancer incidence, Sprague and colleagues estimated that 42 percent of the decline in incidence of breast cancer was linked to the cessation of use.

Sprague said that additional studies are needed to determine the source of the remaining decline in breast cancer cases.

"This does not mean that women should start taking hormones again, but there appear to be additional factors that have contributed to the decline in breast cancer," he said.

Source: American Association for Cancer Research (news : web)

Explore further: Team identifies source of most cases of invasive bladder cancer

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Cancer stem cells linked to drug resistance

16 hours ago

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Unraveling the 'black ribbon' around lung cancer

Apr 17, 2014

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

User comments : 0

More news stories

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Finnish inventor rethinks design of the axe

(Phys.org) —Finnish inventor Heikki Kärnä is the man behind the Vipukirves Leveraxe, which is a precision tool for splitting firewood. He designed the tool to make the job easier and more efficient, with ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.